Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC

2 years ago

Conference call and live audio webcast scheduled for today at 8:30 a.m. ESTTransformative acquisition significantly expands Salarius’ oncology pipeline into…

PacBio Names Lara Toerien as Vice President and General Manager for the Americas

2 years ago

Industry Veteran Will Lead Company’s Commercial Growth Strategy in Americas RegionMENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio…

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.

2 years ago

Franchise includes AMZEEQ® for the treatment of acne and ZILXI® for the treatment of rosacea, and a development-stage dermatology program…

Tiziana Life Sciences Announces Death of Director

2 years ago

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies…

VYNE Therapeutics Divests Topical Minocycline Assets

2 years ago

Transaction includes cash payments of $25 million and potential milestones of up to $450 million Sale aligns with VYNE’s strategic…

Acutus Medical’s Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium

2 years ago

CARLSBAD, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on…

Immuron Receives European Patent on Drug Composition to Treat Travelers’ Diarrhea

2 years ago

MELBOURNE, Australia, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on…

Global Wholehealth Partners Corporation Declares Special Common Stock Dividend

2 years ago

San Clemente, CA, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- On January 13, 2022, Global Wholehealth Partners Corporation…

Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in Phase 1b/2 Clinical Trial of ADG106 in Combination with Nivolumab in Singapore

2 years ago

Clinical trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration…